Three Pharmacy Regulations Health Execs Should Watch

Overview


Emily Cook commented on the federal program, 340B.“Among the expressed concerns are that the program is not governed by clear rules, making it difficult to hold participating providers and drug manufacturers accountable for compliance with program requirements,” Cook says.